Accordingly, as compared with subcutaneous tumor cells, CTNNB1 mRNA was significantly up-regulated while RBM3 protein was significantly down-regulated in cancer cells growing in bone (Fig. 6e), which was consistent with our in vitro observations (see Result 2). This evidence concerns the gene RBM3 and cancer.